Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

Adaptive Biotechnologies

Veracyte

Natera

CareDx

Beam Therapeutics

Guardant Health Inc

Schrodinger 

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

The emergence of the Omicron variant of the coronavirus carries myriad implications for data collection, healthcare innovation, and science, among other fields. There are investment implications as well, including for genomics assets.

Omicron Variant Shows Need to Expand Genomics Capabilities

ARK Fintech Innovation ETF

ARK Industrial Innovation ETF

ARK Web x.0 ETF

ARK Space Exploration & Innovation ETF

After a period of underperformance, some ARK investors are jumping ship.

ARK Funds Leaking Assets

Global X Artificial Intelligence & Technology ETF

ARK Innovation ETF

Global X Blockchain ETF

Global X Robotics & Artificial Intelligence ETF

Global X Genomics & Biotechnology ETF

iShares Cloud 5G and Tech ETF

iShares Genomics Immunology and Healthcare ETF

iShares Robotics & Artificial Intelligence Multisector ETF

First Trust Indxx Innovative Transaction & Process ETF

Invesco Dynamic Biotechnology & Genome ETF

The 3D Printing ETF

ROBO Global Robotics and Automation ETF

Simplify Volt RoboCar Disruption and Tech ETF

Wisdomtree BioRevolution Fund

Investment strategies geared to the future evaluate complex dynamics that can evolve rapidly. As innovation's market share has grown, investment capacity - as measured by average days to trade - also has improved significantly.

Equity Market Cap For Technologically Enabled Innovation Likely To Grow Exponentially

Disruptive, next-generation healthcare strategies, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG), are scuffling this year, but those struggles belie opportunity — something the healthcare sector is ripe with. The broader healthcare sector is delivering solid performances this year, but innovative exchange traded funds, such as ARKG, are being left behind as the growth spots [.

Opportunity Could Be Knocking for Disruptive Healthcare Strategies

Healthcare innovators, including genomics companies, are rarely inexpensive in equity market terms. Often, rich multiples are simply the cost of admission that investors have to pay to access a high-growth parts of the healthcare sector.

Some Value Available in High Octane Healthcare ETF

Burning Rock Biotech

The ARK Genomic Revolution ETF ARKG, +2.01% started a position in Burning Rock Biotech BNR, +10.69% , a Chinese cancer sequencing technology company that jumped 11% after reporting third-quarter results. The loss-making biotech saw its revenue edge up 2% in the third quarter and is planning two products for early-stage cancer patients next year.

ARK Genomic Revolution fund starts position in Burning Rock Biotech

As markets cycle through equities and generate volatility, this can impact some innovative companies. However, pullbacks are often opportunities for investors to capitalize on the innovations that can change the world.

Innovation: How to Navigate Through Periods of Volatility With ARK Invest

Join us for a triple-header to determine the best genomics biotech ETF!

ETF Battles: ARKG Vs IDNA Vs GNOM

Johnson & Johnson

Novo Nordisk

Investing gets simple if you have to put all of your eggs in one basket.

If I Could Only Own 1 Healthcare Stock, This Is What It Would Be

Macro headwinds sure made it challenging for investors to make good money out of the benchmark S&P 500 index in the third quarter. But did ones with money in Cathie Wood's Ark ETFs had it any better?

Did Cathie Wood beat the benchmark in the third quarter?

A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday.

Cathie Wood's ARK Invest Buys Over 675,000 More Shares of CRISPR

Futures edged higher on Wednesday evening as earnings season is about to kick off.

Cathie Wood's ARK Invest Trades for 10/13

A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Friday.

Cathie Wood's ARK Invest Buys Over 400,000 Shares of CRISPR

Genomics is one of the cornerstones of disruptive growth in the healthcare sector. Relevant to investors is that genomics is still in its nascent stages, indicating that there's a potentially lengthy runway ahead for impressive long-term gains.

Gilded Age of Genomics Just Getting Started

ARK Genomic Revolution Multi-Sector ETF focuses on healthcare companies. The fund targets companies with high growth potential.

ARKG Offers Solid Investment Opportunity With Focus On Growth Firms

Google parent Alphabet (NASDAQ:GOOG) has a long history of disruption and one that extends far beyond internet search and advertising. As such, it's not surprising that the stock makes appearances in exchange traded funds such as the ARK Space Exploration and Innovation ETF (ARKX) and the ARK Autonomous Technology & Robotics ETF (CBOE: ARKQ).

Google Getting Into Genomics? It Already Is

Genomics is one of the epicenters of futuristic healthcare investing, and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is one of the top exchange traded funds for accessing that theme. Adding credibility to the long-term genomics investment thesis is the role genomics companies play in earlier cancer detection.

Early Cancer Detection: Major Opportunity for Genomics Investors

ALPS Disruptive Technologies ETF

Goldman Sachs Innovate Equity ETF

Global X Thematic Growth ETF

SPDR S&P Kensho New Economies Composite ETF

Direxion Moonshot Innovators ETF

Main Thematic Innovation ETF

What's better: a diversity of themes or a diversity of stocks in a theme?

Broad Vs Narrow Thematic ETFs

As experienced investors know, it takes some patience to engage with genomics stocks. That's just the lay of the land with one of the more volatile, yet promising, growth-rich corners of the healthcare sector.

Genomics Could Again Be Prime Time Idea

Pfizer

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc.

Cathie Wood's ARK Invest Buys Over 150,000 Shares of This COVID-19 Vaccine Supplier

In spite of rocky performance in 2021, investors are still betting on ARK Funds' bright future.

ARK ETF Investors Not Getting Seasick

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.3 million shares of Sema4 Holdings Corp.

Cathie Wood's ARK Invest Buys Over 1.3 Million Shares of This Health Information Company

Editas Medicine

Intellia Therapeutics

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

How Are Genomics ETFs Responding to Q2 Earnings?

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp.

Cathie Wood's ARK Invest Buys Over 7 Million Shares of This Biotech-Focused SPAC

Soaring Eagle Acquisition Corp

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought nearly 2 million shares of Soaring Eagle Acquisition Corp.

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)